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There are more H atoms than any other type of atom in an X-ray crystal
structure of a protein–ligand complex, but as H atoms only have one electron
they diffract X-rays weakly and are ‘hard to see’. The positions of many H atoms
can be inferred by our chemical knowledge, and such H atoms can be added with
confidence in ‘riding positions’. For some chemical groups, however, there is
more ambiguity over the possible hydrogen placements, for example hydroxyls
and groups that can exist in multiple protonation states or tautomeric forms.
This ambiguity is far from rare, since about 25% of drugs have more than one
tautomeric form. This paper focuses on the most common, ‘prototropic’,
tautomers, which are isomers that readily interconvert by the exchange of an H
atom accompanied by the switch of a single and an adjacent double bond.
Hydrogen-exchange rates and different protonation states of compounds (e.g.
buffers) are also briefly discussed. The difference in heavy (non-H) atom
positions between two tautomers can be small, and careful refinement of all
possible tautomers may single out the likely bound ligand tautomer.
Experimental methods to determine H-atom positions, such as neutron
crystallography, are often technically challenging. Therefore, chemical knowl-
edge and computational approaches are frequently used in conjugation with
experimental data to deduce the bound tautomer state. Proton movement is a
key feature of many enzymatic reactions, so understanding the orchestration of
hydrogen/proton motion is of critical importance to biological chemistry. For
example, structural studies have suggested that, just as a chemist may use heat,
some enzymes use directional movement to protonate specific O atoms on
phosphates to catalyse phosphotransferase reactions. To inhibit ‘wriggly’
enzymes that use movement to effect catalysis, it may be advantageous to have
inhibitors that can maintain favourable contacts by adopting different tautomers
as the enzyme ‘wriggles’.
1. Introduction
The most famous story about tautomers in the history of
science occurred in the early 1950s in Cambridge. Watson and
Crick were trying to propose a structure for DNA, but had
been failing for some time. They were, however, fortunate
enough to be sharing an office with the American theoretical
chemist Jerry Donahue. One Wednesday afternoon they
discussed the possible tautomeric forms of the bases in DNA.
Jerry Donahue told Watson and Crick that the literature was
likely to be wrong and what the most probable tautomers for
G, C, A and T were. When Jim Watson came in to work at
9.30 am on Saturday morning he had cardboard models for the
four bases in the ‘correct’ tautomeric forms and, by the time
that Francis Crick arrived for work at 10.30 am, Jim had
worked out the classical G–C, A–T base pairing (J. Watson
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seminar, LMB, Cambridge, 9th June 2016). As they subse-
quently wrote in their famous paper
If it is assumed that the bases only occur in the most plausible
tautomeric forms . . . it is found that only one specific pair of
bases can bond together
(Watson & Crick, 1953). The normal Watson–Crick base-
pairing for G–C is shown in Fig. 1, which also shows an
unusual G–T base pair that could be made if the guanine
adopted an enol tautomer (Topal & Fresco, 1976). This story
illustrates that understanding tautomers can be important in
understanding molecular-recognition processes, and also how
valuable it can be to know a good chemist.
In an enumeration of 1791 marketed drugs, 74% existed
only as one tautomer, while 26% existed as an average of three
tautomers (Martin, 2009). In principle, it is possible to
experimentally determine the positions of H atoms/protons in
a ligand–protein complex, with the technique of choice being
neutron diffraction (Kwon et al., 2017). While a limited
number of high-resolution neutron structures of ligand
complexes do exist in the PDB (Blakeley, 2016; Fisher et al.,
2012), a 2015 survey showed there were only 83 structures with
neutron data in the PDB, compared with over 90 000 X-ray
crystal structures (Blakeley et al., 2015), perhaps reflecting the
greater technical difficulties in determining neutron structures
(Kwon et al., 2017).
This paper focuses on strategies to address the problem of
how to determine which tautomeric (or protonation) state
your ligand is in when you have determined an X-ray crystal
structure of the complex. It is meant to serve as a brief
introduction and reminder to structural biologists of the
importance of H atoms in biological chemistry. The paper has
sections on ‘Tautomers, protonation states and hydrogen
exchange’ (x2) and ‘Using small-molecule crystal structures to
define ligand chemistry’ (x3), followed by a brief discussion
of ‘When and how to add H atoms to your ligand protein
complex?’ (x4). Two examples of fitting tautomers, AMPPNP
and QPT-1, into macromolecular X-ray crystal structures are
then discussed (x5). The paper concludes with a brief outline
of some ‘Experimental techniques to try to determine where
your H atoms are’ (x6) and ‘Conclusions’ (x7).
2. Tautomers, protonation states and hydrogen
exchange
2.1. Tautomers
Tautomers are compounds that readily interconvert by the
‘movement of an atom (usually hydrogen) or group of atoms
from one site to another within the molecular structure’
(Katritzky et al., 2010). It should be noted that there is no clear
dividing line between isomers and tautomers: ‘tautomers are
simply isomers that convert with a relatively low activation
energy below 20 kcal mol1’ (Katritzky et al., 2010). The focus
of this paper is on the commonest types of tautomer, those
that involve the formal migration of an H atom or proton,
accompanied by a switch of a single bond and an adjacent
double bond (Fig. 2). Ring–chain tautomers, which can play
important roles in isomerization of sugars (Zhu et al., 2001)
and also occur in warfarin (Martin, 2009; Supplementary
Figure S1), will not be discussed further in this paper.
Tautomers in which a C—H bond is cleaved or formed (such
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Figure 1
Comparison of (a) the classical ‘Watson–Crick’ G–C base pair with (b) a
G–T base pair that guanine can make when it adopts a less stable enol
tautomer (dashed arrows from hydrogen-bond donor to acceptor) (Topal
& Fresco, 1976). Marvin was used to draw chemical structures (https://
www.chemaxon.com).
Figure 2
Four common types of tautomerization: keto–enol, amide–imidic acid,
lactam–lactim and amine–imine. Note that a lactam is a cyclic amide.
Marvin was used to draw chemical structures (https://www.chemaxon.com).
as the keto–enol tautomers shown in Fig. 2) can sometimes be
isolated as separate species because breaking or forming a C—
H bond is a relatively slow process (Katritzky et al., 2010). In
contrast, tautomers which involve the exchange of H atoms
between polar atoms (such as amide–imidic acid) are usually
very rapid (exposed main-chain amide H atoms exchange
about 100 times per minute at pH 7).
2.2. Hydrogen exchange
H atoms attached to polar (N and O) atoms that are
exposed to aqueous solvent usually exchange very rapidly.
Fig. 3 shows the exchange rates of labile protons in the small
protein BPTI (Wu¨thrich & Wagner, 1979). In studying protein
structure using hydrogen–deuterium exchange experiments,
main-chain N—H exchange is quenched (but not entirely
eliminated) by lowering the pH to 2.8 (Fig. 3a). The base-
catalysed exchange of the main-chain N—H group probably
proceeds via an imidic acid intermediate (Fig. 3b). The side
chain of a histidine residue has two tautomers when it is not
protonated (Fig. 4, bottom right), while at lower pH both N
atoms on the imidazole ring are protonated and the positive
charge can be stabilized around the aromatic ring (Fig. 4,
bottom left). The two Kekule´ representations of the positively
charged histidine side chain (Fig. 4, bottom left) are inade-
quate (Katritzky et al., 2010) as resonance will stabilize the
positive charge around the aromatic imidazole ring.
2.3. Protonation states
The most common ligands that structural biologists
encounter that have alternative protonation states are buffers.
Fig. 4 shows protonation equilibria of some common buffers.
Note that below pH 7.4 HEPES [(4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid] is a zwitterion, with a negative
charge on the sulfate and a positive charge on one of the N
atoms on the central piperazine ring. In the zwitterionic form
the protonated N atom on the piperazine ring can act as a
hydrogen-bond donor, while the unprotonated N atom can act
as a hydrogen-bond acceptor. The protonation states shown in
Fig. 4 are only those that occur at common pH values. In the
active site of an enzyme unusual protonation states may be
observed; for example, in a joint X-ray and neutron diffraction
study of metal-ion roles and the movement of hydrogen during
a reaction catalysed by d-xylose isomerase, Kovalevsky et al.
(2010) observed that ‘Lys289 is neutral before ring opening
but gains a proton after this’.
3. Using small-molecule crystal structures to define the
ligand chemistry of tautomers
3.1. Generating restraint dictionaries for tautomers
Most modern programs for generating restraint dictionaries
for ligands (Steiner & Tucker, 2017; Long et al., 2017) use
small-molecule crystal structures either from the CSD
(Cambridge Structural Database) or the COD (Crystallo-
graphy Open Database). Small-molecule crystal structures are
also a valuable source of information for the study of tauto-
mers. Although automated ligand-restraint generation can
give excellent dictionaries (Steiner & Tucker, 2017), it can be
informative to look at the crystal structures from which the
restraints are generated. Structures in the CSD can easily be
found and examined with the program ConQuest (Bruno et al.,
2002). Fig. 5 and Table 1 give an example of the different types
of geometry that examination of the CSD with ConQuest
suggests for a PO3—N—PO3 or PO3—NH—PO3 geometry.
Manual examination of the structures suggested that the
geometry of the P—N—P bond may be influenced by the
presence of a metal ion coordinated by two of the O atoms on
the phosphates (Fig. 5 and Table 1); automated programs do
not always spot such subtleties. Sometimes it is necessary to
edit an initial refinement dictionary so that it conforms to the
chemistry of the required tautomer(s).
3.2. Identifying questionable tautomers in small-molecule
crystal structures
One of the reasons that Watson and Crick needed Jerry
Donahue’s advice was because a small-molecule crystal
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Figure 3
(a) Measured exchange rates of some labile protons in a protein (BPTI)
versus pH (adapted from Wu¨thrich & Wagner, 1979). (b) Base-catalyzed
peptide hydrogen–deuterium exchange is likely to proceed via an imidic
acid intermediate. Marvin was used to draw chemical structures (https://
www.chemaxon.com).
structure of a guanine in the literature was in an unusual
tautomer, and Jerry knew from quantum-mechanical calcula-
tions in the literature that the tautomer in the crystal structure
was ‘just a guess’. Today (2016) diffraction data extending to at
least 0.83 A˚ resolution are required for the publication of a
small-molecule crystal structure in Acta Crystallographica
Section C, and at this resolution nearly all H atoms in small-
molecule crystal structures are visible. However, H atoms
often need to be refined with restraints (Sheldrick, 2015), and
questionable tautomers do still occasionally appear in the
Cambridge Structural Database (CSD). In a study of tauto-
mers in the CSD, Cruz-Cabeza & Groom (2011) showed that
simple quantum-mechanical calcula-
tions could be used to identify implau-
sible tautomers where there were
unusually short contacts or large
differences in energies between
observed and putative tautomers.
Interestingly, only some 10% of the
molecules in the CSD were predicted to
have tautomers, and only 0.5% of these
were actually observed as different
tautomers in the CSD (Cruz-Cabeza &
Groom, 2011).
Mogul, a CCDC program (Bruno et
al., 2004), can also be used to help
identify discrepant geometries that
imply incorrectly modelled tautomers.
Mogul can be used to check small-
molecule crystal structures. It compares
bond lengths, bond angles, torsion
angles and some ring angles with those
of similar molecules found in the CSD
and highlights features that are
uncommon and perhaps incorrect. In
some cases this is sufficient to identify
misassigned hydrogen positions. Three
examples of the use of Mogul to
distinguish between pairs of implau-
sible/plausible tautomers are given
below. Cruz-Cabeza & Groom (2011)
point to the structures of 3-chloro-1,2,4-
triazole, where Mogul can distinguish
between the dubious model configura-
tion with CSD refcode CLTRZL and
the more plausible CSD refcode
CLTRZL01 (Claramunt et al., 2001;
Supplementary Fig. S2a). A more recent
example is a comparison of the 1,3-
thiazol-4-one structures with CSD
refcodes GACXOZ and LOQBIE
(Gzella et al., 2014), in which Mogul
queries the C—N bond length of the
imine of GACXOZ, but finds all
geometrical parameters of the amine
version to be within expected limits
(Supplementary Fig. S2b). Unfortu-
nately, Mogul does not always provide a
definitive answer, as in the case of a
comparison of the 2-amino-1,3,4-thia-
diazole configurations with CSD
refcodes UKIRAI and UKIRAI02 (Li
et al., 2014), where both configurations
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Figure 4
Alternative protonation states of some common buffers (note the alternative tautomeric forms of
HEPES at lower pH and histidine at higher pH). Marvin was used to draw chemical structures
(https://www.chemaxon.com).
are deemed to have unusual geometries, although UKIRAI
does have more questionable features (highlighted in red in
Supplementary Fig. S2c) than UKIRAI02. Mogul is a
recommended first step in assessing the atomic configuration
of ligands, along with visual inspection of the modelled
geometry.
4. When and how to add H atoms to your ligand
complex?
Macromolecular crystal structures can be refined with or
without riding H atoms. However, when you deposit your
structure with the PDB, part of the structure-validation
process (Gore et al., 2012) is to add H atoms to the protein
(with Reduce; Word et al., 1999) and to then check them with
MolProbity (Chen et al., 2010; Deis et al., 2013). Ligand-
validation programs (Adams et al., 2016; Emsley, 2017) will
also check for clashes between the ligand and the ligand-
binding pocket once both have been protonated. However,
most modern refinement programs have refinement terms
(Steiner & Tucker, 2017) that try to eliminate unfavourable
van der Waals contacts between H atoms. If your ligand can
have multiple tautomeric states or protonation states, it can be
useful to try and dock and refine all possible tautomeric states
and protonation states into the binding sites. For example (see
below and Chan et al., 2015) we read SMILES (Weininger,
1988) strings for eight tautomers of QPT-1 into an AFITT
(Wlodek et al., 2006) script, and automatically docked each of
the eight into six binding sites. Computational chemistry
programs such as MarvinSketch (Marvin v.16.8.15,
ChemAxon; https://www.chemaxon.com) can be used to
enumerate possible tautomeric and charged states.
The procedure that we recommend for trying to see if you
may have fitted the ‘wrong’ prototropic tautomer or proton-
ation state of your ligand in a complex is as follows.
(i) Refine and fit your ligand to the density as you would
normally do. Quite often differences between tautomers are
quite ‘small’, so which tautomer you fit
initially may not be that important. If
you have fitted the ‘wrong’ tautomer
you might think that you would see a
clash of H atoms; however, unless you
have very high resolution data the
refinement program will often slightly
adjust the conformation of both the
protein and the ligand to avoid such
‘hydrogen’ clashes.
(ii) Delete the ligand from the
‘completed final’ structure and refine
for a few rounds to allow the protein to
‘relax’ into its ‘correct’ conformation
and give the ‘best’ possible difference
map to fit the ligand into.
(iii) Fit all possible tautomers/proto-
nation states of your ligand into this
‘best’ difference map (look at each
carefully on the graphics to check that it
is fitted reasonably into the density) and then refine each
possible solution.
(iv) A final validation check should be made for all possible
solutions, including checking of ligand geometry in the refined
structure(s) with Mogul (Bruno et al., 2004) and careful
examination of maps in Coot (Emsley et al., 2010). The inter-
actions between the ligand and the protein can be examined in
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Figure 5
P—N—P bond angles derived from the CSD. The dotted lines between P
and O atoms indicate that any bond type was allowed in the search of the
CSD with ConQuest. Structures in the CSD which have a metal ion
coordinated by two of the phosphate O atoms have a more acute P—N—
P bond angle, presumably because this brings the two O atoms
coordinating the metal closer together. Marvin was used to draw
chemical structures (https://www.chemaxon.com).
Table 1
Bond distances and angles for a P—NH—P or a P—N P bond derived from the CSD.
The first numbers are from a manual analysis of the most closely related structures in the Cambridge
Structural Database (ConQuest queried with PO3—N—PO3, where ‘any bond’ is allowed between P and
O, and the P—N—P N atom is either NH or is not bonded to a third atom). The numbers in parentheses
are the numbers of this type of bond (or angle) found in the CSD from which the information is derived.
The numbers in bold are those given by Mogul (v.1.7.1), with the estimated standard deviation, when
checking the structures. Note that the P1 and P2 atoms are not covalently bonded, but that the distance
between these two P atoms depends on the P1—N—P2 bond angle, as well as the P—N bond lengths. Note
that for the P—N P angle Mogul only identified two examples, at 134 and 157, giving a standard
deviation of 16.3. On a three standard deviation outlier score Mogul will allow P—N P angles between
98 and 180.
Atoms P—NH—P (No.) P—N P (No.) P—N—P (No.)
P1—N (A˚) 1.64  0.01 (8) 1.59  0.02 (3) 1.58  0.01 (3)†
1.634  0.028 (27) 1.578  0.010 (32) 1.578  0.010 (32)
N P2 (N—P2) (A˚) 1.64  0.01 (8) 1.53  0.01 (3) 1.57  0.02 (3)†
1.634  0.028 (27) 1.528  0.042 (16) 1.528  0.042 (16)
P1, P2 (A˚) 2.97  0.02 (4) 2.86  0.04 (3) 2.78  0.05 (3)†
P1—N—P2 () 130.0  1.0 (4) 133.5  3.0 (3) 124.0  3.0 (3)†
129.859  1.744 (9) 145.533  16.323 (2) 145.533  16.323 (2)
† Two of the phosphate O atoms coordinate a divalent metal ion (see Fig. 5).
Coot with the ‘Ligand’!‘isolated dots for this ligand’
command (Emsley, 2017): this gives a MolProbity-like view of
contacts (including clashes) between the protein and the
ligand (see, for example, Fig. 6).
5. Two examples of tautomers in macromolecular X-ray
crystal structures
5.1. Refining AMPPNP in the ATPase domain of a type IIA
topoisomerase
ATP has two common protonation states in solution, ATP3
and ATP4 (Alberty & Goldberg, 1992), which differ only in
the presence or absence of an H atom on one of the O atoms
on the -phosphate (Supplementary Fig. S3); the presence of
an adjacent Mg2+ ion tends to shift ATP to the ATP4 form. In
AMPPNP the O atom between the -phosphate and -phos-
phate of ATP is replaced by an N atom (Supplementary Fig.
S3). In solution the N atom between the -phosphate and -
phosphate is normally protonated and the compound is known
as adenosine-50-(,-imido)triphosphate (AMPP—NH—P).
In some crystal structures of AMPPNP with proteins this
bridging N atom accepts hydrogen bonds and is in the
unprotonated imino form: adenosine-50-(,-imino)triphos-
phate (AMPP—N P) (Dauter & Dauter, 2011; Agrawal et
al., 2013).
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Figure 6
Comparison of the fitting of (a) AMPP—NH—P or (b) AMPP—N P into a structure. In (c) the imido (P—NH—P) form was fitted into an Fo  Fc
ligand-omit map (shown at 6.5), while in (d) and ( f ) the imino (P—N P or P—N—P) form was fitted into the same map (see Table 1 for restraints).
Small overlaps and bad overlaps are displayed as dots. (e) shows that there are only small differences between the fitted coordinates from (c), (d) and ( f )
and the deposited structure (PDB entry 1pvg; the four structures are shown superposed). (a) and (b) were drawn with Marvin (https://
www.chemaxon.com) and (c), (d), (e) and ( f ) with Coot (Emsley et al., 2010).
Here, we look at fitting two tautomers of AMPPNP4 into a
1.8 A˚ resolution crystal structure of the ATPase region of
Saccharomyces cerevisiae topoisomerase II (PDB entry 1pvg;
Classen et al., 2003; see also Agrawal et al., 2013). A magne-
sium ion is observed next to the phosphates, so the AMPPNP
is more likely to be in the 4 form than the 3 form. Two
tautomers of AMPPNP4 (Fig. 6) were drawn with Marvin-
Sketch, and MarvinSketch was used to write out the corre-
sponding SMILES strings (Marvin v.16.8.15, ChemAxon;
https://www.chemaxon.com). The geometry of small-molecule
crystal structures in the Cambridge Structural Database
(CSD) containing PO3—NH—PO3, PO3—N PO3 or PO3—
N—PO3 were examined manually (see Table 1 and Fig. 5)
using ConQuest (Bruno et al., 2002). It was observed that in
small-molecule structures where two of the phosphate O
atoms coordinate a divalent metal ion the bridging N atom was
not protonated and the geometry was slightly different (data
derived from such structures are indicated in Table 1).
The procedure we used was as follows.
(i) The AMPPNP was deleted from the coordinates of
PDB entry 1pvg, and H atoms were added in Coot
(Coot!Extension!Modelling!‘add H atoms using
REFMAC’) and the structure was refined with REFMAC
(Murshudov et al., 2011). This should allow atoms in the
protein to move to their ‘optimal’ positions without trying to
‘avoid’ clashes with the ligand.
(ii) Dictionaries and coordinates for the two tautomers of
AMPPNP4 (Fig. 6) were generated from the SMILES strings
with AceDRG (Long et al., 2017) and manually edited so that
the geometry of the P—NH—P or P—N—P bonds was as in
Table 1. [The problem of using Kekule´ structures to describe
delocalized bonds is well known (Katritzky et al., 2010), and
can cause problems for dictionary-making programs: in
Supplementary Fig. S3 structures 8, 9 and 10 are different
Kekule´ representations of the same tautomer]. The analysis of
the structures in the CSD suggested two types of dictionary for
the unprotonated imino form (called P—N P and P—N—P
in Table 1), with one dictionary for the imido (NH) form.
(iii) Coordinates for the ligand were real-space refined into
the density (Fig. 6) in Coot, using all three dictionaries. Note
that the real-space fit of the ligand was performed without
coordinates for the protein, so that the ligand would try to
optimally fit the density without ‘knowledge’ of the protein.
(iv) Ligand and protein files were combined in Coot and
clashes checked for (Coot command Ligand!Isolated dots
for Ligand), displaying only ‘bad overlaps’ in Fig. 6 (Coot
command Draw!Generic display objects!Toggling off!
Wide contacts, close contacts and H-bonds).
research papers
Acta Cryst. (2017). D73, 131–140 Bax et al.  Importance of H atoms in biological chemistry 137
Figure 7
Three different tautomers of QPT-1 docked into three similar but slightly different binding sites in complexes of QPT-1 with DNA gyrase (protein) and
DNA (for details, see Chan et al., 2015).
(v) Combined ligand and protein files were written out from
Coot and refined with REFMAC.
(vi) Refined coordinates from the P—NH—P, P—N P and
P—N—P ligands (Table 1) were read into Coot and the
interactions were checked again (with Ligand!Isolated dots
for this ligand etc.). The differences between the deposited
structure in the PDB (1pvg), which does not have H atoms,
and the three re-refined versions are small (Fig. 6e).
With this AMPPNP example, the ‘correct’ answer appears
to be the unprotonated N atom, because otherwise there is a
clash between a backbone amide N atom and the N—H on the
AMPPNP (Fig. 6). However, this ‘clash’ of H atoms can
disappear in refinement, and is somewhat dependent on the
lengths of the bonds to the H atoms (Deis et al., 2013). In
comparing a number of GHKL ATPase structures with
AMPPNP, we noted (Agrawal et al., 2013) that whereas some
GHKL ATPase domain structures had the imido (P—N P)
form bound, others had the imido (P—NH—P) form bound.
These observations prompted us to propose a mechanism for
ATP hydrolysis in which the movement of a main-chain N—H
past the bridging O atom in ATP causes it to protonate the
bridging O atom, resulting in ATP hydrolysis (Supplementary
Fig. S4; the ‘Wellington boot remover model’ of ATP hydro-
lysis).
5.2. Evaluating eight tautomers of QPT-1 (a spirocyclic
barbituric acid) in a DNA–protein complex
QPT-1 is a bacterial topoisomerase inhibitor that was
discovered by Pharmacia in a whole-cell screen for
compounds with antibacterial activity (Miller et al., 2008). A
compound derived from QPT-1, ETX0914 (formerly
AZD0914), has completed a Phase 2 trial for the treatment of
uncomplicated gonorrhoea and is due to go into a Phase 3 trial
in 2017. The barbituric acid moiety of QPT-1 can adopt eight
different tautomeric states (Supplementary Fig. S5).
To try to determine which tautomer was bound in each of
six QPT-1 binding sites (from three DNA-cleavage complexes
of Staphylococcus aureus DNA gyrase), we docked eight
different tautomers into each of the six binding sites (Chan et
al., 2015). The program AFITT (Wlodek et al., 2006), which
can be run from the command line with a script, was used to
dock and score the different possibilities. AFITT has three
types of criteria for evaluating a docking pose: (i) a real-space
correlation coefficient for the fit of the pose to the electron-
density map, (ii) a ligand-strain score and (iii) two scores of
the interaction between the ligand and the pocket, PLP and
Chemscore. Because the eight different tautomers are quite
similar, and because QPT-1 binds in the cleaved DNA making
interactions with bases, we were not 100% certain which
tautomer bound in which site. However, differences between
the six QPT-1 binding sites suggested it was likely that
different binding sites contained different QPT-1 tautomers
(Fig. 7). Analysis of QPT-1 and other DNA complexes
suggested that DNA gyrase ‘wriggles’ to effect the two DNA-
cleavage and two DNA-religation steps in its catalytic cycle
(Chan et al. 2015). It is not clear whether it is advantageous for
compounds such as QPT-1 to be able to adopt different
tautomers/shapes to maintain favourable interactions with
their ligand-binding pocket as the pocket changes shape as the
enzyme–DNA complex ‘wriggles’.
6. Experimental techniques to try to determine where
your H atoms are
X-rays are scattered by electrons and, as hydrogen has only
one electron, hydrogen is seldom visible in a macromolecular
X-ray crystal structure. Even in very high resolution X-ray
crystal structures (1.2–0.65 A˚) not all H atoms are visible in an
electron-density map (Fisher et al., 2012). A recent paper
reviewing ‘Sub-atomic resolution X-ray crystallography and
neutron crystallography’ (Blakeley et al., 2015) stated that
While some details relating to H-atom positions are tractable
with X-ray crystallography at sub-atomic resolution, the
mobility of certain H atoms precludes them from being located.
In addition, highly polarized H atoms and protons (H+) remain
invisible with X-rays.
Electrons are charged particles and interact with both
nuclei and electrons. A recent 1.4 A˚ resolution micro-electron
diffraction study of crystals of the toxic core of -synuclein (a
short peptide) showed difference density for five out of a
possible 73 protons at 2.8 (Rodriguez et al., 2015). However,
high-resolution (better than 1.4 A˚) electron diffraction is not
yet easy to obtain and electrons, like X-rays, cause radiation
damage.
Neutrons are scattered by nuclei, and the coherent scat-
tering of neutrons by both hydrogen and its isotope deuterium
is similar in size to the coherent scattering by other elements.
Neutron crystallography is, in principle, the method of choice
for experimentally determining the positions of H atoms
(Blakeley et al., 2015). In a 1.1 A˚ resolution neutron structure
of crambin, 299 out of 315 (94.9%) of the H-atom positions
were experimentally determined (Chen et al., 2012). However,
neutron crystallography remains technically challenging; in
2015 there were 83 macromolecular structures deposited in
the PDB from neutron diffraction data, compared with more
than 90 000 structures from X-ray data (Blakeley et al., 2015).
Neutron crystallography has been used to probe several
reaction mechanisms in which protons or H atoms move, and
has shown the presence of hydroxide (OH) or hydronium
(H3O
+) ions (see, for example, Coates et al., 2001; Kovalevsky
et al., 2010; Cuypers et al., 2013; Casadei et al., 2014).
NMR spectroscopy is probably the most popular technique
for studying the tautomerism of small-molecule ligands in
solution (Claramunt et al., 2006). Its utility in determining the
structural integrity of synthetic compounds that chemists rely
so heavily on can be used to good effect to determine the
experimentally found tautomeric states and their relative
populations (see, for example, Zhu et al., 2001). This allows the
study of tautomeric equilibria and how factors such as pH,
solvent and temperature can influence the most stable tauto-
mers present. NMR studies are therefore as rich a source of
information as computational studies of ligands alone.
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Unfortunately, when a ligand is bound to a protein the sheer
number of NMR signals from the protein often swamp those
from the ligand, making it much more difficult to extract the
ligand information required to determine the bound tautomer.
One way to get around this is by isotopically labelling the
ligand with a low-abundance NMR-active isotope such as 13C
or 15N or introducing an unusual NMR-active atom such as 19F
into the ligand; this can help to filter out the protein signals
and permit ligand-focused studies (Roberts, 1999).
7. Conclusions
Since Watson & Crick (1953) ‘assumed that the bases only
occur in the most plausible tautomeric forms’ structural and
computational studies have shown that the four bases in DNA
(G, C, A and T) do indeed each have only one stable tautomer
(Saenger, 1983). Nevertheless, minor tautomeric forms of the
DNA bases have been speculated to play a role in mutagenic
mispairings during DNA replication (Topal & Fresco, 1976;
Singh et al., 2015), and in RNA biochemistry different tauto-
meric forms of bases can play important roles in the catalytic
activity of ribozymes (Singh et al., 2015). The transfer of
protons (H+) or hydride ions (H) clearly plays a key role in
many reactions catalysed by enzymes (see, for example, the
proposed mechanism for ATP hydrolysis in Supplementary
Fig. S5), but definitively proving such mechanisms is challen-
ging.
Although neutron crystallography (Blakeley, 2016) and
other techniques can sometimes be used to determine the
tautomeric state of a bound drug (Aggarwal et al., 2016), for
most routine X-ray crystal structures of protein–ligand
complexes there will not be experimental evidence for the
positions of the H atoms, and their positions must be inferred
using chemical knowledge. The two examples presented in this
paper show contrasting ease of determining the ‘correct’
tautomer. For some AMPPNP structures manual examination
of crystal structures shows that hydrogen-bond donors point
at the N atom between the -phosphate and -phosphate,
suggesting that it cannot be protonated. In contrast, in crystal
structures of the antibacterial QPT-1 the docking and refine-
ment of several different tautomers suggests that different
QPT-1 molecules may adopt different tautomeric states as the
compound-binding pocket changes shape, but exactly which
tautomer is bound in each similar but slightly differently
shaped pocket is not certain.
It has recently been reported that the refinement of high-
resolution X-ray structures with a quantum-mechanical force
field and the careful calculation of difference maps can help to
determine which tautomer is bound (Borbulevych et al., 2016).
However, sometimes chemical common sense and careful
evaluation of all possibilities may be all that is required.
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